Drug Use and Addiction Research Programs in Maryland
CFDA 93.279 — federal program obligations to Maryland
Total obligated
$840.8M
Awards
292
USAspending.gov records $851,031,260.81 in Drug Use And Addiction Research Programs obligations (CFDA 93.279) with place of performance in Maryland, across 282 awards. Two hundred eighty-two instruments against $851.03 million imply about $3.02 million per award. This page joins NIDA catalog 93.279 to the MD geography tag. It is not a SAMHSA treatment-block-grant cell, not a clinic census, and not cash already paid. Obligations are not outlays.
Key figures
- CFDA 93.279 shows $851,031,260.81 in Maryland obligations on 282 awards.
- The mean is about $3.02 million per award.
- The catalog is NIDA research, not a SAMHSA treatment block grant.
- Maryland is a place-of-performance tag, not a clinic or patient census.
- Figures are obligations, not outlays.
Maryland crossed with CFDA 93.279
CFDA 93.279 is titled DRUG USE AND ADDICTION RESEARCH PROGRAMS. Crossed with Maryland place of performance, obligations sum to $851,031,260.81 on 282 awards. The national 93.279 hub includes other states. Maryland’s spending hub includes other programs. Only this intersection is reported here. $851,031,260.81 is an obligation aggregate from USAspending.gov, not an outlay and not a count of treatment beds in Baltimore.
Two hundred eighty-two awards is a multi-project extramural research pattern: NIDA assistance often posts as hundreds of discrete records rather than one statewide block. The join does not name recipients. Packet facts are $851,031,260.81, 282 awards, MD, and 93.279. Correlation is not causation. FEC donations do not fund this USAspending cell. Keep NIDA addiction research and Maryland together when reading $851,031,260.81.
93.279 is not a SAMHSA treatment grant in Maryland
Substance-abuse prevention and treatment block grants use different CFDA numbers. Mixing those series into $851,031,260.81 would invent a broader total than this cell contains. Facts available: Maryland, CFDA 93.279, $851,031,260.81, 282 awards. Study titles, activity codes, and overdose statistics are unpublished.
The catalog title names drug use and addiction research programs, not a ranking of treatment providers. Dividing $851,031,260.81 by 282 yields about $3.02 million per award. Unique recipients are unpublished. 282 is not a clinic or patient census.
Full analysis: NIDA addiction research obligations in Maryland →
Questions
- How much NIDA research funding is obligated in Maryland?
- USAspending records $851,031,260.81 in CFDA 93.279 obligations with Maryland place of performance on 282 awards. That is the pair total, not an outlay. Keep Drug Use And Addiction Research Programs and Maryland together when citing $851,031,260.81.
- Does 282 awards mean 282 clinics in Maryland?
- 282 is a USAspending award-record count, not a clinic or patient census. The implied mean is about $3.02 million per award. Unique recipients are unpublished. 282 is a record count, not a person or facility census.
- Is this Maryland’s total federal behavioral-health spending?
- No. This join is CFDA 93.279 only. Treatment block grants and other HHS catalogs appear on separate Maryland program pages. Nationwide 93.279 is not limited to Maryland. Obligations of $851,031,260.81 are not outlays. The overlay is the live NIDA addiction research–Maryland table.
- Do these obligations equal research completed?
- No. $851,031,260.81 is an obligation sum. Outlays are a different USAspending series. Drawdowns can lag the federal obligation. This packet has no outlay total. Original filings remain on USAspending.gov for this 93.279 × MD pair.
USAspending.gov CFDA program aggregates by place of performance state. Obligations are not outlays.
How this pair fits
Explore related views: National Drug Use and Addiction Research Programs profile · All programs in Maryland · All spending in Maryland